.jpg)
Best-in-Class Genetic Medicines with Plug-and-Play Delivery
Strand Signal Stack has produced a diverse pipeline of tissue-specific delivery platforms.
Solid Tumor Delivery Platform
Program
Modality
Indication
Payload
Discovery
Preclinical Development
IND-Enabling
Phase 1
Phase 2
STX-001
Self-replicating mRNA
Melanoma and Solid Tumors
IL-12
More Details
Program
Modality
Indication
Payload
Discovery
Preclinical Development
IND-Enabling
Phase 1
Phase 2
STX-003
Self-replicating mRNA circuit for intravenous delivery
NSCLC and Solid Tumors
IL-12
More Details
Program
Modality
Indication
Payload
Discovery
Preclinical Development
IND-Enabling
Phase 1
Phase 2
STX-005
Circular mRNA circuit for in vivo °ä´¡¸éÌý°Õ
Autoimmune Disease and Hematological Malignancies
CAR
More Details
Platform
Modality
Indication
Payload
STX-001
Self-replicating mRNA
Melanoma and Solid Tumors
IL-12
Discovery
Preclinical Development
IND-Enabling
Phase 1
Phase 2
More Details
Platform
Modality
Indication
Payload
STX-001
Self-replicating mRNA circuit for intravenous delivery
NSCLC and Solid Tumors
IL-12
Discovery
Preclinical Development
IND-Enabling
Phase 1
Phase 2
More Details
Platform
Modality
Indication
Payload
STX-001
Circular mRNA circuit for in vivo CAR T
Autoimmune Disease and Hematological Malignancies
CAR
Discovery
Preclinical Development
IND-Enabling
Phase 1
Phase 2
More Details
Solid Tumor Delivery Platform
Platform
Modality
Indication
Payload
Discovery
Preclinical Development
IND-Enabling
Phase 1
STX-001
Solid Tumor Delivery Platform
Self-replicating mRNA
Melanoma and solid tumors
IL-12
STX-003
Solid Tumor Delivery Platform
Self-replicating mRNA circuit for intravenous delivery (non-liver)
NSCLC and solid tumors
IL-12
STX-005
T Cell Delivery Platform
Circular RNA circuit for intravenous delivery (T cells)
Hematological malignancies
CAR
We Reach More Patients Faster by Working Together
Every biopharma company shouldn’t need to re-invent a delivery system for genetic medicine.
Together, we can use our infrastructure and innovations to deliver safe, effective genetic medicines to millions of new patients across indications and tissue targets.
